Featured Research

from universities, journals, and other organizations

Steroids More Effective Than Antihistamines When Used As Needed For Allergies

Date:
November 27, 2001
Source:
University Of Chicago Medical Center
Summary:
Researchers from the University of Chicago have demonstrated that corticosteroid nasal sprays are more effective than antihistamines when used "as needed" for treatment of seasonal allergies. This finding, published in the November 26 issue of the Archives of Internal Medicine, suggests that the current guidelines and prescribing patterns, which favor the use of antihistamines as the first-line treatment for mild or moderate allergies, need to be revised.

Researchers from the University of Chicago have demonstrated that corticosteroid nasal sprays are more effective than antihistamines when used "as needed" for treatment of seasonal allergies. This finding, published in the November 26 issue of the Archives of Internal Medicine, suggests that the current guidelines and prescribing patterns, which favor the use of antihistamines as the first-line treatment for mild or moderate allergies, need to be revised.

One out of five people in the United States suffers from a seasonal allergy such as hay fever. Both corticosteroid sprays and antihistamines can prevent allergy symptoms such as sneezing, runny nose, congestion and watery eyes when used continuously. But very few patients take these medications continuously. Most take them sporadically, in response to symptoms.

"Changing the current guidelines to match patient practice would help more people and reduce health care costs," said Robert Naclerio, M.D., chief of otolaryngology-head and neck surgery at the University of Chicago and director of the study.

Although antihistamines are prescribed three times as often as corticosteroids, "we found that intranasal corticosteroids are more effective than antihistamines when used as needed, which is how most patients take these medications," he added. "Plus, they cost less than the non-sedating antihistamines."

The researchers enrolled 88 patients with ragweed allergies in a four-week study during the 1999 hay fever season. The patients, 44 in each group, were matched for allergy severity. One group was told to take a standard dose -- two sprays in each nostril -- of the corticosteroid fluticasone (Flonase) whenever they felt symptoms. The other group was told to take one tablet of the non-sedating antihistamine, loratadine (Claratin).

Total symptoms were similar when the patients began the study. Significant differences began to emerge after five days, however, and they remained until the end of the study at 28 days.

The steroid nasal spray group reported far fewer symptoms such as sneezing, runny nose and congestion over the four weeks than the antihistamine group. Their scores on a quality-of-life survey -- which looked at the impact of allergies on factors such as sleep, emotions and daily activities -- also showed significantly fewer allergy-related problems.

In addition, the nasal spray group also had better scores for various biomarkers of an allergic reaction. They had fewer eosinophils -- a type of immune cell associated with allergies -- at two weeks and at four weeks, when the study ended. They also had lower levels of eosinophil cationic protein, another allergy marker.

"The findings fit perfectly with our growing understanding of the mechanisms of seasonal allergies," said Naclerio.

People with hay fever react within minutes to contact with ragweed pollen. They sneeze and their eyes itch and water. The biology of this early response includes histamine release.

This early response is followed in a few hours by the late response, an influx in the sinuses of immune cells such as eosinophils and an increase in nasal reactivity to the allergen, called "priming."

Antihistamines can block the actions of histamines if taken in advance but they have no impact on the late response. Intranasal steroids inhibit the late response and prevent priming.

"Antihistamines," explained Naclerio, "taken once symptoms have already appeared, arrive too late to block the early response and have little effect on the late response. Corticosteroids taken when symptoms begin can prevent the late response and inhibit priming, which makes the patient more sensitive to subsequent contacts."

"Our study," he added, "demonstrates the greater importance of the late response compared to the immediate response."

The authors emphasize that continuous medication use is more effective than sporadic use in response to symptoms but acknowledge that few patients comply with those instructions.

In light of their findings, they suggest revising the current guidelines so that "intranasal corticosteroids should become the first-line treatment for seasonal allergies. They should now be recommended for regular use in patients with severe disease," said Naclerio, "and for as-needed use in patients with mild disease."

This study was supported in part by grants from Glaxo Wellcome Inc., Research Triangle Park, N.C., and from the National Institutes of Health, Bethesda, Md.


Story Source:

The above story is based on materials provided by University Of Chicago Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

University Of Chicago Medical Center. "Steroids More Effective Than Antihistamines When Used As Needed For Allergies." ScienceDaily. ScienceDaily, 27 November 2001. <www.sciencedaily.com/releases/2001/11/011127004650.htm>.
University Of Chicago Medical Center. (2001, November 27). Steroids More Effective Than Antihistamines When Used As Needed For Allergies. ScienceDaily. Retrieved August 22, 2014 from www.sciencedaily.com/releases/2001/11/011127004650.htm
University Of Chicago Medical Center. "Steroids More Effective Than Antihistamines When Used As Needed For Allergies." ScienceDaily. www.sciencedaily.com/releases/2001/11/011127004650.htm (accessed August 22, 2014).

Share This




More Health & Medicine News

Friday, August 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Newsy (Aug. 21, 2014) An experimental drug used to treat Marburg virus in rhesus monkeys could give new insight into a similar treatment for Ebola. Video provided by Newsy
Powered by NewsLook.com
Two US Ebola Patients Leave Hospital Free of the Disease

Two US Ebola Patients Leave Hospital Free of the Disease

AFP (Aug. 21, 2014) Two American missionaries who were sickened with Ebola while working in Liberia and were treated with an experimental drug are doing better and have left the hospital, doctors say on August 21, 2014. Duration: 01:05 Video provided by AFP
Powered by NewsLook.com
Cadavers, a Teen, and a Medical School Dream

Cadavers, a Teen, and a Medical School Dream

AP (Aug. 21, 2014) Contains graphic content. He's only 17. But Johntrell Bowles has wanted to be a doctor from a young age, despite the odds against him. He was recently the youngest participant in a cadaver program at the Indiana University NW medical school. (Aug. 21) Video provided by AP
Powered by NewsLook.com
American Ebola Patients Released: What Cured Them?

American Ebola Patients Released: What Cured Them?

Newsy (Aug. 21, 2014) It's unclear whether the American Ebola patients' recoveries can be attributed to an experimental drug or early detection and good medical care. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins